We analyze a new paper by Arora et al. that compares the ability of one of these strains, A.30, which contains a highly mutated S protein, to avoid neutralization by antibodies derived from convalescent sera, monoclonal antibody treatment, or vaccine.
Spike And Nucleocapsid Protein Mutations In Tanzanian And Ugandan Strains Of SARS-CoV-2 Demand Attention
